Exhibit 10.6


 


SECOND AMENDED AND RESTATED UNIT PRIVATE
PLACEMENT AGREEMENT


 


This Second Amended and Restated Unit Private
Placement Agreement (this “Second Amended and Restated Agreement”) is entered into as of [], 2022, by and between Hudson
Acquisition I Corp., a Delaware corporation (the “Company”) and Hudson SPAC Holding LLC, a Delaware limited liability
company (the “Purchaser”). Each of the Company and Purchaser shall be referred to as a “Party” and
collectively, the “Parties”.


 


RECITALS


 


WHEREAS, the Parties entered
into certain Amended and Restated Unit Private Placement Agreement dated February 4, 2022 (the “Amended and Restated Agreement”),
pursuant to which the Purchaser agreed to purchase from the Company on the Closing Date 340,000 Initial Units at $10.00 per Initial Unit
in connection with the Company’s initial public offering (the “IPO”) in the amount of $60,000,000, each Unit
consisting of one share of the Company’s common stock and one right to receive one-tenth (1/10) of a share;


 


WHEREAS, the Parties have
determined to change the terms of the Rights as set forth below;


 


WHEREAS, each Party agrees
that the Amended and Restated Agreement is hereby terminated as of the date hereof, shall be of no further force or effect and completely
replaced by this Second Amended and Restated Agreement;


 


WHEREAS, as a result of such
changes, the Parties desire to enter into this second amended and restated unit private placement agreement.


 


NOW, THEREFORE, in consideration
of the promises and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:


 


1. Agreement
to Subscribe


 


1.1. Purchase
and Issuance of the Initial Units. For the aggregate sum of $3,400,000 (the “Initial Purchase Price”), upon
the terms and subject to the conditions of this Second Amended and Restated Agreement, the Purchaser hereby agrees to purchase from the
Company, and the Company hereby agrees to sell to the Purchaser, on the Closing Date (as defined in Section 1.2) 340,000 units (the “Initial
Units”) at $10.00 per Initial Unit.


 


In addition to the foregoing,
the Purchaser hereby agrees to purchase up to an additional 27,000 Units (“Additional Units” and together with
the Initial Units, the “Units”) at $10.00 per Additional Unit for a purchase price of $270,000 (the “Additional
Purchase Price” and together with the Initial Purchase Price, the “Purchase Price”). The purchase
and issuance of the Additional Units shall occur only in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment
Option”) in the Offering is exercised in full or part. The total number of Additional Units to be purchased hereunder shall
be in the same proportion as the amount of the Over-Allotment Option that is exercised. Each purchase of Additional Units shall occur
simultaneously with the consummation of any portion of the Over-Allotment Option.


 






    1/10


    


    

 


1.2. Closing.
The closing (the “Closing”) of the Offering shall take place at the offices of Sichenzia Ross Ference LLP, 1185
Avenue of the Americas, 31st Floor, New York, New York, 10036 simultaneously with the consummation of the Company’s IPO
of six million (6,000,000) units. Each unit offered in this private placement Offering and the Company’s IPO shall consist of one
share of common stock of the Company, par value $0.0001 per share (the “Common Shares”), and one right (the
“Right”) to receive one-eighth (1/8) of one Common Share (the “Right Shares”) to be
governed by the Rights Agreement (defined herein) and the consummation of the exercise of all or any portion of the Over-Allotment Option
(each a “Closing Date”).


 


1.3. Delivery of the Purchase Price. At
least one business day prior to the effective date of the Company’s registration statement relating to the IPO (“Registration
Statement”), or the date of the exercise of the Over-Allotment Option, if any, the Purchaser agrees to deliver the Initial
Purchase Price or Additional Purchase Price, as the case may be, by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars to an escrow agent to be identified prior to the Closing (“Escrow Agent”), which
is hereby irrevocably authorized to deposit such funds on the applicable Closing Date to the trust account which will be established for
the benefit of the Company’s public shareholders, managed pursuant to that certain Investment Management Trust Agreement to be entered
into by and between the Company and Escrow Agent and into which substantially all of the proceeds of the IPO will be deposited (the “Trust
Account”). If the IPO is not consummated within 14 days of the date the Initial Purchase Price is delivered to Escrow Agent,
the Initial Purchase Price shall be returned to the Purchaser by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars, without interest or deduction.


 


1.4.
Delivery of Unit Certificate. Upon the applicable Closing Date after delivery of the Purchase Price in accordance with Section
1.3, the Purchaser shall become irrevocably entitled to receive a unit certificate representing the Units purchased hereunder.


 


2. Representations
and Warranties of the Purchaser


 


The Purchaser represents and warrants to the Company that:


 


2.1. No
Government Recommendation or Approval. It understands that no United States federal or state agency or a similar agency of any other
country has passed upon or made any recommendation or endorsement of the Company, the Offering, the Units, the Rights, the Right Shares,
or the Common Shares underlying the Units (excluding the Right Shares, the “Unit Shares” and, collectively with
the Units and the Right Shares, the “Securities”).


 


2.2. Organization.
The Purchaser is a company, validly existing and in good standing under the laws of its jurisdiction and possesses all requisite power
and authority necessary to carry out the transactions contemplated by this Second Amended and Restated Agreement.


 






    2/10


    


    

 


2.3. Private
Offering. It is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act
of 1933, as amended (the “Securities Act”). It acknowledges that the sale contemplated hereby is being made in reliance on
a private placement exemption to “Accredited Investors” within the meaning of Section 501(a) of Regulation D under the Securities
Act.


 


2.4. Authority. This Second Amended and
Restated Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding agreement enforceable
in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance
or similar laws affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless
of whether enforcement is sought in a proceeding at law or in equity).


 


2.5. No
Conflicts. The execution, delivery and performance of this Second Amended and Restated Agreement and the consummation by the Purchaser
of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the Purchaser’s organizational
documents, (ii) any agreement, indenture or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation
to which the Purchaser is subject, or any agreement, order, judgment or decree to which the Purchaser is subject.


 


2.6. No
Legal Advice from Company. It acknowledges it has had the opportunity to review this Second Amended and Restated Agreement
and the transactions contemplated by this Second Amended and Restated Agreement and the other agreements entered into between the parties
hereto with its own legal counsel and investment and tax advisors. Except for any statements or representations of the Company made in
this Second Amended and Restated Agreement and the other agreements entered into between the parties hereto, it is relying solely on such
counsel and advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax
or investment advice with respect to this investment, the transactions contemplated by this Second Amended and Restated Agreement or the
securities laws of any jurisdiction.


 


2.7. Access
to Information; Independent Investigation. Prior to the execution of this Second Amended and Restated Agreement, it has had the opportunity
to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances,
operations, business and prospects of the Company, and the opportunity to obtain additional information to verify the accuracy of all
information so obtained. In determining whether to make this investment, it has relied solely on its own knowledge and understanding of
the Company and its business based upon its own due diligence investigation and the information furnished pursuant to this paragraph.
It understands that no person has been authorized to give any information or to make any representations which were not furnished pursuant
to this Section 2 and it has not relied on any other representations or information in making its investment decision, whether written
or oral, relating to the Company, its operations and/or its prospects.


 






    3/10


    


    

 


2.8. Reliance
on Representations and Warranties. It understands the Units are being offered and sold to it in reliance on exemptions from the registration
requirements under the Securities Act, and analogous provisions in the laws and regulations of various states, and that the Company is
relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Purchaser
set forth in this Second Amended and Restated Agreement in order to determine the applicability of such provisions.


 


2.9. No
Advertisements. It is not subscribing for the Units as a result of or subsequent to any advertisement, article, notice or other communication
published in any newspaper, magazine, or similar media or broadcast over television or radio, or presented at any seminar or meeting.


 


2.10. Legend.
It acknowledges and agrees the certificates evidencing the Units, the Common Shares, the Rights and the Common Shares underlying the Rights
shall bear a restrictive legend (the “Legend”), in form and substance as set forth in Section 4 hereof, prohibiting
the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration statement covering these securities
under the Securities Act or (ii) pursuant to any other exemptions from the registration requirements under the Securities Act and such
laws which, in the opinion of counsel for the Company, is available.


 


2.11. Experience,
Financial Capability and Suitability. It is (i) sophisticated in financial matters and is able to evaluate the risks and benefits
of the investment in the Securities and (ii) able to bear the economic risk of his investment in the Securities for an indefinite period
of time because the Securities have not been registered under the Securities Act and therefore cannot be sold unless subsequently registered
under the Securities Act or an exemption from such registration is available. It has substantial experience in evaluating and investing
in transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment
in the Company and has the capacity to protect its own interests. It has substantial experience in evaluating and investing in transactions
of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company
and has the capacity to protect its own interests.


 


2.12. Investment
Purposes. It is purchasing the Securities solely for investment purposes, for its own account and not for the account or benefit of
any other person, and not with a view towards the distribution or dissemination thereof and it has no present arrangement to sell the
interest in the Securities to or through any person or entity.


 


2.13. Restrictions
on Transfer. It acknowledges and understands the Units are being offered in a transaction not involving a public offering in the United
States within the meaning of the Securities Act. The Securities have not been registered under the Securities Act, and, if in the future,
it decides to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise
transferred only


 


(A)  pursuant
to an effective registration statement filed under the Securities Act,


 


(B) pursuant
to an exemption from registration under Rule 144 promulgated under the Securities Act (“Rule 144”), if available,
or


 






    4/10


    


    

 


(C) pursuant
to any other available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable
securities laws of any state or any other jurisdiction. It agrees that if any transfer of its Securities or any interest therein is proposed
to be made, as a condition precedent to any such transfer, it may be required to deliver to the Company an opinion of counsel satisfactory
to the Company. Absent registration or another available exemption from registration, it agrees it will not resell the Securities. It
further acknowledges that because the Company is a shell company, Rule 144 may not be available to it for the resale of the Securities
until the one year anniversary following consummation of the initial Business Combination (defined below) of the Company, despite technical
compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions.


 


3. Representations
and Warranties of the Company


 


The Company represents and warrants to the Purchaser that:


 


3.1. Valid
Issuance of Share Capital. The total number of all classes of share capital which the Company has authority to issue is 200,000,000
shares of common stock. As of the date hereof, the Company has issued 1,725,000 Common Shares (225,000 shares of which are subjected to
forfeiture and none are subject to redemption as described in the registration statement related to the IPO). All of the issued share
capital of the Company has been duly authorized, validly issued, and are fully paid and non-assessable.


 


3.2. Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the rights agreement to be entered into
with Escrow Agent on or prior to the closing of the IPO (the “Rights Agreement”), as the case may be, each of
the Rights and the Common Shares will be duly and validly issued, fully paid and non-assessable. On the date of issuance of the Units
and the Right Shares shall have been reserved for issuance. Upon issuance in accordance with the terms hereof and the Rights Agreement,
the Purchaser will have or receive good title to the Right Shares, free and clear of all liens, claims and encumbrances of any kind other
than (i) transfer restrictions hereunder and pursuant to the insider letter to be entered into on or prior to the closing of the IPO (the
“Insider Letter”) and (ii) transfer restrictions under federal and state securities laws.


 


3.3. Organization
and Qualification. The Company has been duly incorporated and is validly existing as a Delaware business company and has the requisite
corporate power to own its properties and assets and to carry on its business as now being conducted.


 


3.4. Authorization;
Enforcement. (i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this
Second Amended and Restated Agreement and to issue the Securities in accordance with the terms hereof, (ii) the execution, delivery and
performance of this Second Amended and Restated Agreement by the Company and the consummation by it of the transactions contemplated hereby
have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors
or shareholders is required, and (iii) this Second Amended and Restated Agreement constitutes, and upon the execution and delivery thereof,
the Rights and Rights Agreement, will constitute, valid and binding obligations of the Company enforceable against the Company in accordance
with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance,
moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies
or by equitable principles of general application and except as enforcement of rights to indemnity and contribution may be limited by
federal and state securities laws or principles of public policy.


 






    5/10


    


    

 


3.5 No
Conflicts. The execution, delivery and performance of this Second Amended and Restated Agreement and the consummation by the Company
of the transactions contemplated hereby do not (i) result in a violation of the Company’s bylaws and Certificate of Incorporation,
conflict with, or constitute a default under any agreement, indenture or instrument to which the Company is a party or (iii) conflict
with any law, statute, rule or regulation to which the Company is subject or any agreement, order, judgment or decree to which the Company
is subject. Other than any federal, state or foreign securities filings which may be required to be made by the Company subsequent to
the Closing, and any registration statement which may be filed pursuant thereto, the Company is not required under federal, state or local
law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental
agency or self-regulatory entity in order for it to perform any of its obligations under this Second Amended and Restated Agreement or
issue the Units, the Rights or the Common Shares underlying the Units, Rights in accordance with the terms hereof.


 


4. Legends


 


4.1. Legend.
The Company will issue the Units, the Rights and the Unit Shares, and when issued, the Right Shares purchased by the Purchaser, in the
name of the Purchaser. The Securities will bear the following Legend and appropriate “stop transfer” instructions:


 


THESE SECURITIES (i) HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B)
TO A NON-U.S. PERSON IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C)
PURSUANT TO THE RESALE LIMITATIONS SET FORTH IN RULE 905 OF REGULATION S UNDER THE SECURITIES ACT, (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION
PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION.
HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.


 


“THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO AN AGREEMENT BETWEEN HUDSON ACQUISITION I CORP. AND HUDSON SPAC HOLDING, LLC AND MAY NOT BE OFFERED, SOLD, TRANSFERRED,
PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT TO THE TERMS SET FORTH THEREIN.”


 


4.2. Purchaser’s
Compliance. Nothing in this Section 4 shall affect in any way the Purchaser’s obligations and agreements to comply with all
applicable securities laws upon resale of the Securities.


 


4.3. Company’s
Refusal to Register Transfer of the Securities. The Company shall refuse to register any transfer of the Securities, if in the sole
judgment of the Company such purported transfer would not be made (i) pursuant to an effective registration statement filed under the
Securities Act, or (ii) pursuant to an available exemption from the registration requirements of the Securities Act.


 


4.4. Registration
Rights. The Purchaser will be entitled to certain registration rights which will be governed by a registration rights agreement (“Registration
Rights Agreement”) to be entered into with the Company on or prior to the closing of the IPO.


 


5. Lockup


 


The Purchaser acknowledges
and agrees that the Units, the Rights, the Unit Shares, and the Right Shares shall not be transferable, saleable or assignable until thirty
(30) days after the consummation of an acquisition, share exchange, purchase of all or substantially all of the assets of, or any other
similar business combination with one or more businesses or entities (a “Business Combination”), except to permitted
transferees (as defined in the Insider Letter).


 


6. Securities
Laws Restrictions


 


The Purchaser agrees not to
sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Securities unless, prior thereto (a) a registration
statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Securities proposed
to be transferred shall then be effective or (b) the Company shall have received an opinion from counsel reasonably satisfactory to the
Company, that such registration is not required because such transaction complies with the Securities Act and the rules promulgated by
the Securities and Exchange Commission thereunder and with all applicable state securities laws.


 


7. Waiver
of Distributions from Trust Account


 


In connection with the Securities
purchased pursuant to this Second Amended and Restated Agreement, the Purchaser hereby waives any and all right, title, interest or claim
of any kind in or to any distributions from the Trust Account.


 


8. Rescission
Right Waiver and Indemnification


 






    6/10


    


    

 


8.1. Rescission
Waiver. The Purchaser understands and acknowledges that an exemption from the registration requirements of the Securities Act requires
there be no general solicitation of purchasers of the Units. In this regard, if the Offering were deemed to be a general solicitation
with respect to the Units, the offer and sale of such Units may not be exempt from registration and, if not, the Purchaser may have a
right to rescind its purchase of the Units. In order to facilitate the completion of the Offering and in order to protect the Company,
its shareholders and the Trust Account from claims that may adversely affect the Company or the interests of its shareholders, the Purchaser
hereby agrees to waive, to the maximum extent permitted by applicable law, any claims, right to sue or rights in law or arbitration, as
the case may be, to seek rescission of its purchase of the Units as a result of the issuance of the Units being deemed to be in violation
of Section 5 of the Securities Act. The Purchaser acknowledges and agrees this waiver is being made in order to induce the Company to
sell the Units to the Purchaser. The Purchaser agrees the foregoing waiver of rescission rights shall apply to any and all known or unknown
actions, causes of action, suits, claims or proceedings (collectively, “Claims”) and related losses, costs,
penalties, fees, liabilities and damages, whether compensatory, consequential or exemplary, and expenses in connection therewith, including
reasonable attorneys’ and expert witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing
or defending against any Claims, whether pending or threatened, in connection with any present or future actual or asserted right to rescind
the purchase of the Units hereunder or relating to the purchase of the Units and the transactions contemplated hereby.


 


8.2. No
Recourse Against Trust Account. The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever
in connection with its purchase of the Units or any Claim that may arise now or in the future.


 


8.3. Section
8 Waiver. The Purchaser agrees that to the extent any waiver of rights under this Section 8 is ineffective as a matter of law, the
Purchaser has offered such waiver for the benefit of the Company as an equitable right that shall survive any statutory disqualification
or bar that applies to a legal right. The Purchaser acknowledges the receipt and sufficiency of the consideration received from the Company
hereunder in this regard.


 


9. Terms
of the Unit


 


The Units shall be substantially
identical to the Units offered in the IPO as set forth in the Underwriting Agreement, except the Units: (i) will be subject to the transfer
restrictions described herein, and (ii) are being purchased pursuant to an exemption from the registration requirements of the Securities
Act and will become freely tradable only after certain conditions are met or the resale of the Units is registered under the Securities
Act.


 


10. Governing
Law; Jurisdiction; Waiver of Jury Trial


 


This Second Amended and Restated
Agreement shall be governed by and construed in accordance with the laws of Delaware for agreements made and to be wholly performed within
such territory. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Second Amended
and Restated Agreement and the transactions contemplated hereby.


 






    7/10


    


    

 


11. Assignment;
Entire Agreement; Amendment


 


11.1. Assignment.
Neither this Second Amended and Restated Agreement nor any rights hereunder may be assigned by any party to any other person other than
by the Purchaser, without the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon such
assignment by a Purchaser, the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided for herein to
the extent of such assignment.


 


11.2. Entire
Agreement. This Second Amended and Restated Agreement sets forth the entire agreement and understanding between the parties
as to the subject matter hereof and supersedes any and all prior discussions, agreements and understandings of any and every nature.


 


11.3. Amendment.
Except as expressly provided in this Second Amended and Restated Agreement, neither this Second Amended and Restated Agreement nor any
term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the party against whom enforcement
of any such amendment, waiver, discharge or termination is sought.


 


11.4. Binding
upon Successors. This Second Amended and Restated Agreement shall be binding upon and inure to the benefit of the parties hereto
and to their respective heirs, legal representatives, successors and permitted assigns.


12. Notices;
Indemnity


 


12.1 Notices.
All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party’s
address set forth herein or to such other address as a party may designate by notice hereunder, and shall be either (a) delivered by hand,
(b) sent by overnight courier, or (c) sent by certified mail, return receipt requested, postage prepaid. All notices, requests, consents
and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the
receiving party at the address of such party set forth above, (ii) if sent by overnight courier, on the next business day following the
day such notice is delivered to the courier service, or (iii) if sent by certified mail, on the fifth business day following the day such
mailing is made.


 


12.2 Indemnification.
Except as set forth in Section 8, each party shall indemnify the other party against any loss, cost or damages (including reasonable attorney’s
fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement set forth
in this Second Amended and Restated Agreement.


 


13. Counterparts


 


This Second Amended and Restated
Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form
of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such signature page were an original thereof.


 






    8/10


    


    

 


14. Survival;
Severability


 


14.1. Survival.
The representations, warranties, covenants and agreements of the parties hereto shall survive the Closing until one (1) year following
the consummation of an initial Business Combination.


 


14.2.
Severability. In the event that any provision of this Second Amended and Restated Agreement becomes or is declared by a court
of competent jurisdiction to be illegal, unenforceable or void, this Second Amended and Restated Agreement shall continue in full force
and effect without said provision; provided that no such severability shall be effective if it materially changes the economic benefit
of this Second Amended and Restated Agreement to any party.


 


15. Headings


 


The titles and subtitles used
in this Second Amended and Restated Agreement are used for convenience only and are not to be considered in construing or interpreting
this Second Amended and Restated Agreement.


 


16. Construction


 


The parties hereto have participated
jointly in the negotiation and drafting of this Second Amended and Restated Agreement. If an ambiguity or question of intent or interpretation
arises, this Second Amended and Restated Agreement will be construed as if drafted jointly by the parties hereto and no presumption or
burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Second Amended
and Restated Agreement. The words “include,” “includes,” and “including” will
be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed
to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context
otherwise requires. The words “this Second Amended and Restated Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Second Amended and Restated Agreement
as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty,
and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant
contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject
matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the
fact that such party hereto is in breach of the first representation, warranty, or covenant.


 


[Remainder of page intentionally left blank]


 






    9/10


    


    

 


This Second Amended and Restated Agreement is
accepted by the Company as of the date first written above.


 


	HUDSON ACQUISITION I CORP.	 
	 	 	 
	By:	 	 
	Name:	Jiang Hui	 
	Title:	Chief Executive Officer	 
	 	 	 
	Accepted and agreed this [ ]th day of April, 2022	 
	 	 	 
	HUDSON SPAC HOLDING, LLC	 
	 	 	 
	By:	 	 
	Name:	Xiaoyue Zhang	 
	Title:	Authorized Signatory	 



 


 


10/10